Clinical trial
Combinazione HMA e Venetoclax Con Posaconazolo in Pazienti Affetti da Leucemia Acuta Mieloide: Studio Delle Concentrazioni Plasmatiche
NCT07254611 is registered in ClinicalTrials.gov with Fondazione IRCCS Policlinico San Matteo di Pavia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combinazione HMA e Venetoclax Con Posaconazolo in Pazienti Affetti da Leucemia Acuta Mieloide: Studio Delle Concentrazioni Plasmatiche
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 12, 2022
- Completion date
- February 15, 2023
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aml (acute myelogenous leukemia